News | April 4, 2017

EvidenceCare Introduces Suite Of Hospital Acquired Condition Pathways Designed To Help Hospitals Improve Patient Outcomes And Reduce Lengths Of Stay

NASHVILLE, TENN.--(BUSINESS WIRE)--

EvidenceCare, a Nashville-based decision support tool for physicians, announces the addition of a suite of clinical pathways designed for Hospital-Acquired Condition (HAC) reduction and treatment. The conditions covered within the initial collection include Catheter-Associated Urinary Tract Infection (CAUTI), Central Line-Associated Bloodstream Infection (CLABSI), and Clostridium Difficile (C. Diff), three conditions which, together, represent 40% of the patients affected by Hospital-Associated Infections (HAI).

A 2014 HAI Prevalence Survey reported there was an estimated 722,000 HAIs in U.S. acute care hospitals. In U.S. hospitals alone, HAIs infect 1 in 20 patients and result in more than 100,000 deaths. Hospital Associated Infections (HAI) cost up to $45 billion in excess medical expenditures and result in immeasurable suffering.

The Hospital-Acquired Condition Reduction Program was created under the Affordable Care Act to incentivize hospitals to curb HAIs and other hospital-acquired conditions. Under this program, the federal government cuts Medicare payments for hospitals with the highest rate of hospital-acquired conditions. In 2017, 769 hospitals will lose 1 percent of Medicare payments for ranking in the worst-performing quartile of hospitals that report hospital-acquired conditions. It is estimated that hospitals will lose approximately $430 million, 18 percent more than last year.

“Publishing clinical content that impacts patient outcomes and improves overall hospital performance is a stalwart of our company,” stated EvidenceCare’s CEO, Dr. Brian Fengler. “And, delivering it in a way that enhances provider workflow and provides actionable evidence-based recommendations at the bedside provides better access to imperative information,” he continued.

EvidenceCare was conceived to solve a fundamental need for healthcare providers to find and quickly digest the latest treatment guidelines. The company’s patent-pending technology was pioneered by Dr. Brian Fengler, an emergency room physician, and offers a unique dashboard interface that presents evidence-based treatment recommendations that are specific to the patient being treated.

EvidenceCare’s decision support tool enhances provider workflow and propels the patient-provider relationship by delivering the latest medical content in a manner that is quickly and easily consumable by clinicians at the bedside. The company works with industry leading experts and medical societies to create content in some of the most complex and costly conditions in healthcare.

The free web-based tool includes content for conditions ranging from Pneumonia and Pulmonary Embolisms to Diabetic Emergencies, Sepsis and Stroke. Enterprise solutions include full integration with a hospital’s Electronic Health Records and track CME for the time spent in the system. Clinical professionals can access EvidenceCare at www.evidence.care.

About EvidenceCare

Nashville-based EvidenceCare is a clinical decision support platform designed by practicing emergency physician, Dr. Brian Fengler. Unlike any tool on the market, EvidenceCare provides clinicians with access to patient specific evidence-based treatment recommendations at the bedside in as little as 30 seconds. Since its launch in July 2016, the company’s proprietary content publishing platform is delivering protocols authored by industry-leading experts to nearly 1800 providers worldwide. To learn more visit www.evidence.care.


Copyright Business Wire 2017